Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation

International Journal of Molecular Medicine

Volumn 33, Issue 1, 2014, Pages 178-184

  Park, Kyungho ^a,b   Ju, Won Chul ^a   Yeo, Joo Hong ^c   Kim, Jong Youl ^b   Seo, Ho Seong ^d   Uchida, Yoshikazu ^b   Cho, Yunhi ^a  

^a Kyung Hee University   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c National Institute of Animal Science   (South Korea)

^d Korea Atomic Energy Research Institute   (South Korea)

Author keywords

Osteoblast conditioned medium; Osteoclast differentiation; Osteoprotegerin; Receptor activator of nuclear factor B ligand; Soybean

Indexed keywords

GELATINASE B; ISOFLAVONE DERIVATIVE; MESSENGER RNA; NUCLEAR FACTOR OF ACTIVATED T CELL C1; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLASTOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SOYBEAN; UNITED STATES;

ANIMALS; CELL DIFFERENTIATION; CULTURE MEDIA, CONDITIONED; GENISTEIN; ISOFLAVONES; MATRIX METALLOPROTEINASE 9; MICE; NFATC TRANSCRIPTION FACTORS; NIH 3T3 CELLS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; PLANT EXTRACTS; RANK LIGAND; RNA, MESSENGER; SOYBEANS;

EID: 84892694666     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1557     Document Type: Article

References (32)

1. Spelsberg TC, Subramaniam M, Riggs BL and Khosla S: The actions and interactions of sex steroids and growth factor/cytokines on the skeleton. Mol Endocrinol 13: 819-828, 1999.
2. Barton M and Shapiro D: Transient administration of estradiol-17 beta establishes an autoregulatory loop permanently inducing estrogen receptor mRNA. Proc Natl Acad Sci USA 85: 7119-7123, 1998.
3. Babiker FA, De Windt LJ, van Eickels M, Grohe C, Meyer R and Doevendans PA: Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc Res 53: 709-719, 2002.
4. Kang KS, Morita I, Cruz A, Jeon YJ, Trosko JE and Chang CC: Expression of estrogen receptors in a normal human breast epithelial cell type with luminal and stem cell characteristics and its neoplastically transformed cell lines. Carcinogenesis 18: 251-257, 1997.
5. Lindgren PR, Cajander S, Bäckström T, Gustafsson JA, Mäkelä S and Olofsson JI: Estrogen and progesterone receptors in ovarian epithelial tumors. Mol Cell Endocrinol 221: 97-104, 2004.
6. Couse JF, Lindzey J, Grandien K, Gustafsson JA and Korach KS: Tissue distribution and quantitative analysis of estrogen receptoralpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 138: 4613-4621, 1997.
7. Ernst M, Schmid C and Froesch ER: Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci USA 85: 2307-2310, 1988.
8. Okazaki R, Inoue D, Shibata M, Saika M, Kido S, Ooka H, Tomiyama H, Sakamoto Y and Matsumoto T: Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology 143: 2349-2356, 2002.
9. Balica M, Boström K, Shin V, Tillisch K and Demer LL: Calcifying subpopulation of bovine aortic smooth muscle cells is responsive to 17 beta-estradiol. Circulation 95: 1954-1960, 1997.
10. Bord S, Ireland DC, Beavan SR and Compston JE: The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32: 136-141, 2003.
11. Kameda T, Mano H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamaru Y, Hiroi E, Hiura K, Kameda A, Yang NN, Hakeda Y and Kumegawa M: Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J Exp Med 186: 489-495, 1997.
12. Collier FM, Huang WH, Holloway WR, Hodge JM, Gillespie MT, Daniels LL, Zheng MH and Nicholson GC: Osteoclasts from human giant cell tumors of bone lack estrogen receptors. Endocrinology 139: 1258-1267, 1998.
13. Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Joffe M, Rosner B, Fuchs C, Hankinson SE, Hunter DJ, Hennekens CH and Speizer FE: Postmenopausal hormone therapy and mortality. N Engl J Med 336: 1769-1775, 1997.
14. Compston JE: Sex steroids and bone. Physiol Rev 81: 419-447, 2001.
15. Keinan-Boker L, van Der Schouw YT, Grobbee DE and Peeters PH: Dietary phytoestrogens and breast cancer risk. Am J Clin Nutr 79: 282-288, 2004.
16. Setchell KD and Lydeking-Olsen E: Dietary phytoestrogens and their effect on bone: evidence from in vitro and in vivo, human observational, and dietary intervention studies. Am J Clin Nutr 78 (Suppl 3): 593S-609S, 2003.
17. Kim J, Um SJ, Woo J, Kim JY, Kim HA, Jang KH, Kang SA, Lim BO, Kang I, Choue RW and Cho Y: Comparative effect of seeds of Rhynchosia volubilis and soybean on MG-63 human osteoblastic cell proliferation and estrogenicity. Life Sci 78: 30-40, 2005.
18. Qu Q, Härkönen PL, Mönkkönen J and Väänänen HK: Conditioned medium of estrogen-treated osteoblasts inhibits osteoclast maturation and function in vitro. Bone 25: 211-215, 1999.
19. Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM and Choi Y: The TRAF family of signal transducers mediates NF-kappaB activation by the TRANCE receptor. J Biol Chem 273: 28355-28359, 1998.
20. Ishida N, Hayashi K, Hoshijima M, Ogawa T, Koga S, Miyatake Y, Kumegawa M, Kimura T and Takeya T: Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem 277: 41147-41156, 2002.
21. Park K, Elias PM, Oda Y, Mackenzie D, Mauro T, Holleran WM and Uchida Y: Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway. J Biol Chem 286: 34121-34130, 2011.
22. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R and Boyle WJ: Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319, 1997.
23. Santanam N, Shern-Brewer R, McClatchey R, Castellano PZ, Murphy AA, Voelkel S and Parthasarathy S: Estradiol as an antioxidant: incompatible with its physiological concentrations and function. J Lipid Res 39: 2111-2118, 1998.
24. Khosla S: Minireview: the OPG/RANKL/RANK system. Endocrinology 142: 5050-5055, 2001.
25. Sundaram K, Nishimura R, Senn J, Youssef RF, London SD and Reddy SV: RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp Cell Res 313: 168-178, 2007.
26. Karieb S and Fox SW: Phytoestrogens directly inhibit TNF-α-induced bone resorption in RAW264.7 cells by suppressing c-fos-induced NFATc1 expression. J Cell Biochem 112: 476-487, 2011.
27. null T cells and B lymphopoesis in ovariectomized mice: a key mechanism for anti-osteoclastogenic effect. PLoS One 6: e21216, 2011.
28. García Palacios V, Robinson LJ, Borysenko CW, Lehmann T, Kalla SE and Blair HC: Negative regulation of RANKL-induced osteoclastic differentiation in RAW264.7 cells by estrogen and phytoestrogens. J Biol Chem 280: 13720-13727, 2005.
29. Lorget F, Kamel S, Mentaverri R, Wattel A, Naassila M, Maamer M and Brazier M: High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem Biophys Res Commun 268: 899-903, 2000.
30. Gao YH and Yamaguchi M: Suppressive effect of genistein on rat bone osteoclasts: Involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int J Mol Med 5: 261-267, 2000.
31. Fu YX, Gu JH, Zhang YR, Tong XS, Zhao HY, Yuan Y, Liu XZ, Bian JC and Liu ZP: Osteoprotegerin influences the bone resorption activity of osteoclasts. Int J Mol Med 31: 1411-1417, 2013.
32. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T and Taniguchi T: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3: 889-901, 2002.